Lipoprotein Particles in Adolescents and Young Women With PCOS Provide Insights Into Their Cardiovascular Risk

Area of Science:

• Endocrinology
• Cardiovascular Science
• Metabolic Health

Background:

• Polycystic ovarian syndrome (PCOS) is associated with increased cardiovascular disease risk in adult women, but this link is debated in younger populations.
• Low-density lipoprotein (LDL) particle number, assessed via nuclear magnetic resonance spectroscopy, offers a novel approach to cardiovascular risk evaluation.

Purpose of the Study:

• To investigate lipoprotein particle number and size in young women diagnosed with PCOS.
• To determine the relationship between lipoprotein profiles, insulin resistance, and hyperandrogenism in this demographic.

Main Methods:

• A cross-sectional, case-control study design was employed.
• Participants included 35 women with PCOS and 20 healthy controls.
• Nuclear magnetic resonance spectroscopy was used to measure LDL particle size and number, with secondary analysis correlating LDL particle number with inflammatory markers and metabolic parameters.

Main Results:

• Women with PCOS displayed significantly higher LDL particle numbers compared to controls (935 ± 412 vs. 735 ± 264, P = .032).
• Elevated LDL particle number strongly correlated with high-sensitivity C-reactive protein and waist-to-hip ratio.
• The increase in LDL particle number was primarily driven by small LDL particles (sLDLp), which correlated with insulin resistance markers (Matsuda index, HOMA-IR) and adiponectin levels.

Conclusions:

• Adolescent and young women with PCOS present an atherogenic lipoprotein profile, suggesting heightened cardiovascular risk.
• This increased risk appears to be mediated by the extent of visceral adiposity and the degree of insulin resistance.